Evaluating the HER-2 status of breast cancer using mammography radiomics features

被引:39
|
作者
Zhou, Jing [1 ,2 ,4 ]
Tan, Hongna [1 ,2 ]
Bai, Yan [1 ,2 ]
Li, Jie [3 ]
Lu, Qing [1 ,2 ]
Chen, Rushi [1 ,2 ]
Zhang, Menghuan [1 ,2 ]
Feng, Qin [1 ,2 ]
Wang, Meiyun [1 ,2 ]
机构
[1] Henan Prov Peoples Hosp, Dept Radiol, 7 Rd,Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China
[2] Imaging Diag Neurol Dis & Res Lab Henan Prov, Zhengzhou, Henan, Peoples R China
[3] Huiying Med Technol Inc, Beijing, Peoples R China
[4] Mudanjiang Med Univ, Med Imaging Sch, Mudanjiang 157011, Heilongjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Breast cancer; HER-2; Radiomics; Mammography; THERAPY;
D O I
10.1016/j.ejrad.2019.108718
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The aim of our study was to evaluate the HER-2 status in breast cancer patients using mammography (MG) radiomics features. Methods: A total of 306 Chinese female patients with invasive ductal carcinoma of no special type (IDC-NST) enrolled from January 2013 to July 2018 were divided into a training set (n= 244) and a testing set (n= 62). One hundred and eighty-six radiomics features were extracted from digital MG images based on the training set. The least absolute shrinkage and selection operator (LASSO) method was used to select the optimal predictive features for HER-2 status from the training set. Both support vector machine (SVM) and logistic regression models were employed based on the selected features. The area under the receiver operating characteristic (ROC) curves (AUCs) of the training set and testing set were used to evaluate the predictive performance of the models. Results: Compared with the SVM model, the performance of the logistic regression model using a combination of cranial caudal (CC) and mediolateral oblique (MLO) MG views was optimal. In the training set, the sensitivity, specificity, accuracy and area under the curve (AUC) values of the logistic regression model for evaluating HER-2 status based on quantitative radiomics features were 87.29%, 58.73%, 80.00% and 0.846 (95% confidence interval (CI), 0.800-0.887), respectively, and in the testing set, the values were 73.91%, 68.75%, 77.00% and 0.787 (95% CI, 0.673-0.885), respectively. Conclusions: Radiomics features could be an efficient tool for the preoperative evaluation of HER-2 status in patients with breast cancer.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Moderate Immunohistochemical Expression of HER-2 (2+) Without HER-2 Gene Amplification Is a Negative Prognostic Factor in Early Breast Cancer
    Rossi, Valentina
    Sarotto, Ivana
    Maggiorotto, Furio
    Berchialla, Paola
    Kubatzki, Franziska
    Tomasi, Nicoletta
    Redana, Stefania
    Martinello, Rossella
    Valabrega, Giorgio
    Aglietta, Massimo
    Ponzone, Riccardo
    Montemurro, Filippo
    ONCOLOGIST, 2012, 17 (11): : 1418 - 1425
  • [22] A Radiomics Study: Classification of Breast Lesions by Textural Features from Mammography Images
    Letchumanan, Nishta
    Wong, Jeannie Hsiu Ding
    Tan, Li Kuo
    Ab Mumin, Nazimah
    Ng, Wei Lin
    Chan, Wai Yee
    Rahmat, Kartini
    JOURNAL OF DIGITAL IMAGING, 2023, 36 (04) : 1533 - 1540
  • [23] Comparison of fluorescence in situ hybridization and immunohistochemistry for assessment of HER-2 status in breast cancer patients
    Lin Wang
    Xiaobei Wang
    Xiu Nie
    Ling Ma
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2009, 29 : 354 - 358
  • [24] Review of the clinical status of cardiotoxicity of HER-2 positive breast cancer targeted therapeutic drugs
    Zhang, Xiang
    Yin, Yulian
    Yu, Qiuting
    Chen, Xinlin
    Cheng, Yiqin
    FRONTIERS IN ONCOLOGY, 2025, 14
  • [25] A Radiomics Study: Classification of Breast Lesions by Textural Features from Mammography Images
    Nishta Letchumanan
    Jeannie Hsiu Ding Wong
    Li Kuo Tan
    Nazimah Ab Mumin
    Wei Lin Ng
    Wai Yee Chan
    Kartini Rahmat
    Journal of Digital Imaging, 2023, 36 : 1533 - 1540
  • [26] Comparison of Fluorescence in situ Hybridization and Immunohistochemistry for Assessment of HER-2 Status in Breast Cancer Patients
    Wang, Lin
    Wang, Xiaobei
    Nie, Xiu
    Ma, Ling
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2009, 29 (03) : 354 - 358
  • [27] Clinical outcome of adjuvant endocrine treatment according to Her-2/neu status in breast cancer
    James, Rani
    Thriveni, K.
    Krishnamoorthy, Lakshmi
    Deshmane, Vijayalaxmi
    Bapsy, P. P.
    Ramaswamy, Girija
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2011, 133 (01) : 70 - 75
  • [28] Comparison of Fluorescence in situ Hybridization and Immunohistochemistry for Assessment of HER-2 Status in Breast Cancer Patients
    王琳
    王晓蓓
    聂秀
    马玲
    Current Medical Science, 2009, 29 (03) : 354 - 358
  • [29] HER-2/neu Status: A Neglected Marker of Prognostication and Management of Breast Cancer Patients in India
    Zubeda, Syeda
    Kaipa, Prabhakar Rao
    Shaik, Noor Ahmad
    Mohiuddin, Mohammed Khaliq
    Vaidya, Sireesha
    Pavani, Boddana
    Srinivasulu, Mukta
    Latha, Manolla Madhavi
    Hasan, Qurratulain
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (04) : 2231 - 2235
  • [30] Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
    Gancberg, D
    Di Leo, A
    Cardoso, F
    Rouas, G
    Pedrocchi, M
    Paesmans, M
    Verhest, A
    Bernard-Marty, C
    Piccart, MJ
    Larsimont, D
    ANNALS OF ONCOLOGY, 2002, 13 (07) : 1036 - 1043